The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.
A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports.
Pharmaceutical company Novo Nordisk has left a group of pharmaceutical companies that are unhappy with proposed drug laws in South Africa.
On January 17, Actavis confirmed that the US District Court for the District of New Jersey found its US patent 7,704,984, which covers Lo Loestrin Fe birth control pills, to be valid and infringed by Lupin and Amneal.
Aurobindo’s European subsidiary is set to acquire Actavis’s commercial generic operations in seven Western European markets in a deal worth about €30 million ($40 million).
South African drug companies have been accused by advocacy organisations of planning a "deceptive" campaign to delay new laws which could see the introduction of more generic medicines.
A US judge has said Teva Pharmaceuticals did not infringe patents belonging to a rival company after seeking approval to market a generic version of the drug.
EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.
The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11.